RXD vs. NOBL
RXD (ProShares UltraShort Health Care) and NOBL (ProShares S&P 500 Dividend Aristocrats ETF) are both exchange-traded funds - RXD is a Leveraged Equities fund tracking the DJ Global United States (All) / Health Care -IND (-200%), while NOBL is a Dividend fund tracking the S&P 500 Dividend Aristocrats Index. Both are passively managed. Over the past 10 years, RXD returned -20.50%/yr vs 10.32%/yr for NOBL. At a correlation of -0.62, they often move in opposite directions. RXD charges 0.95%/yr vs 0.35%/yr for NOBL.
Performance
RXD vs. NOBL - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, RXD achieves a -1.40% return, which is significantly lower than NOBL's 8.38% return. Over the past 10 years, RXD has underperformed NOBL with an annualized return of -20.50%, while NOBL has yielded a comparatively higher 10.32% annualized return.
RXD
- 1D
- -3.08%
- 1M
- -9.66%
- YTD
- -1.40%
- 6M
- 0.04%
- 1Y
- -25.85%
- 3Y*
- -8.16%
- 5Y*
- -7.55%
- 10Y*
- -20.50%
NOBL
- 1D
- 0.79%
- 1M
- 4.19%
- YTD
- 8.38%
- 6M
- 7.32%
- 1Y
- 15.05%
- 3Y*
- 8.82%
- 5Y*
- 6.42%
- 10Y*
- 10.32%
RXD vs. NOBL - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
RXD ProShares UltraShort Health Care | -1.40% | -21.66% | 4.83% | 3.25% | 1.20% | -37.97% | -44.25% | -32.44% | -14.33% | -35.24% |
NOBL ProShares S&P 500 Dividend Aristocrats ETF | 8.38% | 6.84% | 6.72% | 8.09% | -6.52% | 25.46% | 8.35% | 27.39% | -3.26% | 21.02% |
Correlation
The correlation between RXD and NOBL is -0.59, meaning they tend to move in opposite directions. This is especially valuable for risk management - when one declines, the other has historically tended to hold steady or rise.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | -0.59 |
Correlation (3Y) Calculated over the trailing 3-year period | -0.67 |
Correlation (5Y) Calculated over the trailing 5-year period | -0.71 |
Correlation (10Y) Calculated over the trailing 10-year period | -0.65 |
Correlation (All Time) Calculated using the full available price history since Oct 10, 2013 | -0.62 |
The correlation between RXD and NOBL shifts across timeframes, from -0.71 (5 years) to -0.59 (1 year), reflecting how their relationship changes across market environments.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
RXD vs. NOBL — Risk / Return Rank
RXD
NOBL
RXD vs. NOBL - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for ProShares UltraShort Health Care (RXD) and ProShares S&P 500 Dividend Aristocrats ETF (NOBL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| RXD | NOBL | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.17 | ||
| Sortino ratioReturn per unit of downside risk | -3.06 | ||
| Omega ratioGain probability vs. loss probability | 0.87 | 1.22 | -0.35 |
| Calmar ratioReturn relative to maximum drawdown | -0.75 | 1.66 | -2.41 |
| Martin ratioReturn relative to average drawdown | -1.12 | 4.21 | -5.33 |
Loading charts...
Drawdowns
RXD vs. NOBL - Drawdown Comparison
The maximum RXD drawdown since its inception was -99.65%, which is greater than NOBL's maximum drawdown of -35.43%. Use the drawdown chart below to compare losses from any high point for RXD and NOBL.
Loading charts...
Drawdown Indicators
| RXD | NOBL | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.65% | -35.43% | -64.22% |
Max Drawdown (1Y)Largest decline over 1 year | -34.63% | -9.11% | -25.52% |
Max Drawdown (3Y)Largest decline over 3 years | -36.60% | -15.36% | -21.24% |
Max Drawdown (5Y)Largest decline over 5 years | -40.50% | -17.92% | -22.58% |
Max Drawdown (10Y)Largest decline over 10 years | -90.64% | -35.43% | -55.21% |
Current DrawdownCurrent decline from peak | -99.63% | -1.57% | -98.06% |
Average DrawdownAverage peak-to-trough decline | -81.91% | -3.48% | -78.43% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 23.10% | 3.59% | +19.51% |
Volatility
RXD vs. NOBL - Volatility Comparison
ProShares UltraShort Health Care (RXD) has a higher volatility of 10.55% compared to ProShares S&P 500 Dividend Aristocrats ETF (NOBL) at 3.45%. This indicates that RXD's price experiences larger fluctuations and is considered to be riskier than NOBL based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| RXD | NOBL | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 10.55% | 3.45% | +7.10% |
Volatility (6M)Calculated over the trailing 6-month period | 21.92% | 8.29% | +13.63% |
Volatility (1Y)Calculated over the trailing 1-year period | 30.33% | 11.52% | +18.81% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 29.91% | 14.39% | +15.52% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 33.01% | 16.60% | +16.41% |
RXD vs. NOBL - Expense Ratio Comparison
RXD has a 0.95% expense ratio, which is higher than NOBL's 0.35% expense ratio.
Dividends
RXD vs. NOBL - Dividend Comparison
RXD's dividend yield for the trailing twelve months is around 3.01%, more than NOBL's 2.09% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
NOBL ProShares S&P 500 Dividend Aristocrats ETF | 2.09% | 2.14% | 2.05% | 2.09% | 1.94% | 1.89% | 2.14% | 1.89% | 2.37% | 1.74% | 2.13% | 2.02% |
RXD ProShares UltraShort Health Care | 3.01% | 3.29% | 4.36% | 3.17% | 0.67% | 0.00% | 0.17% | 1.73% | 0.22% | 0.00% | 0.00% | 0.00% |
Frequently Asked Questions
RXD and NOBL have a correlation of -0.59, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
RXD has higher volatility (10.55%) compared to NOBL (3.45%). In terms of maximum drawdown, RXD dropped -99.65% vs NOBL's -35.43%.
On 10-year performance, NOBL leads with 10.32% vs -20.50% for RXD. On fees, NOBL is cheaper at 0.35% per year. On volatility, NOBL has been the lower-risk option at 3.45%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 10-year period, NOBL has performed better with a 10.32% return vs -20.50%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
NOBL is cheaper with a 0.35% expense ratio, compared with 0.95% for RXD.
RXD has the higher dividend yield at 3.01%, compared with 2.09% for NOBL.
RXD is categorized as Leveraged Equities, while NOBL is Dividend. RXD tracks DJ Global United States (All) / Health Care -IND (-200%), while NOBL tracks S&P 500 Dividend Aristocrats Index. Their fees differ too: 0.95% for RXD and 0.35% for NOBL.
NOBL currently has the higher Sharpe Ratio (1.32 vs -0.86), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for RXD and NOBL
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer